Will Her Successors Be Loyal to Rome?
Red Cross Rejects Money
The decision suggested that stem-cell research has become so controversial that some major institutions might be scared away.
The government cleared the way for scientists to receive federal money for embryonic stem cell experiments this year.
The National Institutes of Health announced the morning of Feb. 7 that the Red Cross research was the first award to be approved. That afternoon, however, the Red Cross said it had decided not to accept the grant.
Golden Pages: No Abortion Ads?
IRISH INDEPENDENT, Feb. 5 — Advertisements for abortion businesses in Britain may be dropped from the next edition of IrishGolden Pages because of fears they are breaking the law.
The commercial telephone directory is one of the main sources of information for women in Ireland who may travel to England for abortions.
A spokesman for Golden Pages Ltd, jointly owned by Eircom and VNU Publishers, said that after a comprehensive review, legal advisors believe the publication of the ads may be in contravention of 1995 legislation.
A spokesman said the publishers are awaiting legal advice.
More Ultrasounds
ASSOCIATED PRESS, Feb. 1 — Convinced that a look inside the womb would dissuade many pregnant women from abortion, pro-life advocates hope to provide ultrasound equipment to hundreds of pregnancy centers.
Backers of the initiative want to reduce abortion, but say their strategy is non-coercive — they're simply giving women more information.
“When they get the information to make an informed choice — once they see the ultrasound — the majority of women chose to carry the pregnancy to term,” said Tom Glessner, president of the National Institute of Family and Life Advocates.
Abortion/Breast-Cancer Victory
LIFESITE DAILY NEWS, Feb. 7 — Pro-abortion groups are admitting defeat in their attempt to have regulators declare inaccurate an ad presenting scientific evidence of the link between abortion and breast cancer.
In October, the Pro-Choice Action Network filed a formal complaint with Advertising Standards Canada about the abortion-breast cancer ad of Surrey Delta Pro-Life.
Pro-Choice Action's February newsletter reveals that in late December, the standards board declined to review the ad any further. The board said there are “serious and noteworthy considerations in dispute,” but they are “complex” and “beyond [our] resources” and “expertise” to evaluate.
